A S Monto

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. ncbi Vaccines and antiviral drugs in pandemic preparedness
    Arnold S Monto
    University of Michigan School of Public Health, Ann Arbor, Michigan 48109 2029, USA
    Emerg Infect Dis 12:55-60. 2006
  2. ncbi Response to the 2009 pandemic: effect on influenza control in wealthy and poor countries
    Arnold S Monto
    The School of Public Health, University of Michigan ASM, United States
    Vaccine 29:6427-31. 2011
  3. ncbi Invited commentary: Use of selective viral cultures to adjust nonvirologic endpoints in studies of influenza vaccine efficacy
    Arnold S Monto
    Department of Epidemiology, School of Public Health, University of Michigan, 109 Observatory Street, Room 3080 SPH I, Ann Arbor, MI 48109-2029, USA
    Am J Epidemiol 158:312-5. 2003
  4. ncbi Detection and control of influenza outbreaks in well-vaccinated nursing home populations
    Arnold S Monto
    Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI 48109 2029, USA
    Clin Infect Dis 39:459-64. 2004
  5. ncbi Seasonal influenza vaccines: evolutions and future trends
    Arnold S Monto
    University of Michigan School of Public Health, Department of Epidemiology, Ann Arbor, MI 48104, USA
    Expert Rev Vaccines 8:383-9. 2009
  6. ncbi Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use
    Arnold S Monto
    University of Michigan School of Public Health, Ann Arbor, MI 48109, USA
    Antimicrob Agents Chemother 50:2395-402. 2006
  7. ncbi Epidemiology of pandemic influenza: use of surveillance and modeling for pandemic preparedness
    Arnold S Monto
    Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, 48109, USA
    J Infect Dis 194:S92-7. 2006
  8. ncbi Seasonal and pandemic influenza: a 2007 update on challenges and solutions
    Arnold S Monto
    Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, USA
    Clin Infect Dis 46:1024-31. 2008
  9. ncbi Antivirals and influenza: frequency of resistance
    Arnold S Monto
    Department of Epidemiology, University of Michigan, Ann Arbor, MI 48109 2025, USA
    Pediatr Infect Dis J 27:S110-2. 2008
  10. ncbi The risk of seasonal and pandemic influenza: prospects for control
    Arnold S Monto
    Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109 2029, USA
    Clin Infect Dis 48:S20-5. 2009

Research Grants

  1. Comparative Study of Influenza Vaccines in Adults
    ARNOLD MONTO; Fiscal Year: 2006

Detail Information

Publications65

  1. ncbi Vaccines and antiviral drugs in pandemic preparedness
    Arnold S Monto
    University of Michigan School of Public Health, Ann Arbor, Michigan 48109 2029, USA
    Emerg Infect Dis 12:55-60. 2006
    ..Special questions need to be answered if a highly lethal virus, such as influenza A (H5N1), produces the pandemic. Both vaccines and antiviral drugs will be required for a coordinated strategy...
  2. ncbi Response to the 2009 pandemic: effect on influenza control in wealthy and poor countries
    Arnold S Monto
    The School of Public Health, University of Michigan ASM, United States
    Vaccine 29:6427-31. 2011
    ..Only by taking a broad view of influenza on an annual basis can vaccine supplies be ensured for all countries of the world...
  3. ncbi Invited commentary: Use of selective viral cultures to adjust nonvirologic endpoints in studies of influenza vaccine efficacy
    Arnold S Monto
    Department of Epidemiology, School of Public Health, University of Michigan, 109 Observatory Street, Room 3080 SPH I, Ann Arbor, MI 48109-2029, USA
    Am J Epidemiol 158:312-5. 2003
  4. ncbi Detection and control of influenza outbreaks in well-vaccinated nursing home populations
    Arnold S Monto
    Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI 48109 2029, USA
    Clin Infect Dis 39:459-64. 2004
    ..Recommendations for outbreak control in institutions such as nursing homes advises use of antiviral drugs to reduce influenza transmission...
  5. ncbi Seasonal influenza vaccines: evolutions and future trends
    Arnold S Monto
    University of Michigan School of Public Health, Department of Epidemiology, Ann Arbor, MI 48104, USA
    Expert Rev Vaccines 8:383-9. 2009
    ..Such data will be necessary to inform decisions on making selections for use...
  6. ncbi Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use
    Arnold S Monto
    University of Michigan School of Public Health, Ann Arbor, MI 48109, USA
    Antimicrob Agents Chemother 50:2395-402. 2006
    ..The frequency of variants with decreased sensitivity to the NAIs did not increase significantly during this period, but continued surveillance is required, especially in regions with higher NAI use...
  7. ncbi Epidemiology of pandemic influenza: use of surveillance and modeling for pandemic preparedness
    Arnold S Monto
    Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, 48109, USA
    J Infect Dis 194:S92-7. 2006
    ..Models previously used to estimate hospitalizations and mortality associated with past epidemics and pandemics have evolved to estimate the burden and required surge capacity of future pandemics of different severities...
  8. ncbi Seasonal and pandemic influenza: a 2007 update on challenges and solutions
    Arnold S Monto
    Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, USA
    Clin Infect Dis 46:1024-31. 2008
    ..These initiatives will also help control outbreaks of seasonal influenza...
  9. ncbi Antivirals and influenza: frequency of resistance
    Arnold S Monto
    Department of Epidemiology, University of Michigan, Ann Arbor, MI 48109 2025, USA
    Pediatr Infect Dis J 27:S110-2. 2008
    ..Resistance does emerge, but not at the same frequency as with the M2 inhibitors. Resistant viruses also appear less fit and thus less able to spread. However, as use increases, resistance needs to be carefully monitored...
  10. ncbi The risk of seasonal and pandemic influenza: prospects for control
    Arnold S Monto
    Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109 2029, USA
    Clin Infect Dis 48:S20-5. 2009
    ..Stockpiles of antiviral drugs are being established for therapeutic and perhaps preventive use for pandemic influenza...
  11. ncbi Epidemiology of influenza
    Arnold S Monto
    Department of Epidemiology, University of Michigan School of Public Health, 109 Observatory Street, Ann Arbor, MI 48109, USA
    Vaccine 26:D45-8. 2008
    ..Younger individuals experience the highest frequency of illnesses caused by all subtypes. This has resulted in suggested strategies for community control by vaccinating children...
  12. ncbi Influenza control in the 21st century: Optimizing protection of older adults
    Arnold S Monto
    University of Michigan School of Public Health, Ann Arbor, 48109 2029, USA
    Vaccine 27:5043-53. 2009
    ..While it is clear that vaccines with greater immunogenicity are required for older adults, and that adjuvanted vaccines may offer a short-term solution, further research is required to exploit the many other new technologies...
  13. ncbi Comparative efficacy of inactivated and live attenuated influenza vaccines
    Arnold S Monto
    Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI 48109, USA
    N Engl J Med 361:1260-7. 2009
    ..The efficacy of influenza vaccines may vary from year to year, depending on a variety of factors, and may differ for inactivated and live attenuated vaccines...
  14. ncbi Seasonal influenza vaccinations: specialized products for different target groups
    Arnold S Monto
    Dept of Epidemiology, University of Michigan School of Public Health, Ann Arbor, 48109 2029, USA
    Vaccine 28:D14-23. 2010
    ..We will also consider different strategies for vaccine use which might be applied to traditional or future vaccines to improve population protection...
  15. ncbi Seasonal influenza and vaccination coverage
    Arnold S Monto
    Dept of Epidemiology, University of Michigan School of Public Health, Ann Arbor, 48109 2029, USA
    Vaccine 28:D33-44. 2010
    ....
  16. ncbi The role of antivirals in the control of influenza
    Arnold S Monto
    School of Public Health, The University of Michigan, 109 Observatory Street, Ann Arbor, MI 48109 2029, USA
    Vaccine 21:1796-800. 2003
    ..Their availability will depend entirely on the creation of stockpiles of these agents well in advance of the arrival of the pandemic...
  17. ncbi The seasonality of rhinovirus infections and its implications for clinical recognition
    Arnold S Monto
    Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan 48109, USA
    Clin Ther 24:1987-97. 2002
    ..Isolation of rhinoviruses occurs in a distinct and consistent seasonal pattern that can be used to help determine whether an acute respiratory illness is caused by a rhinovirus...
  18. ncbi Influenza vaccine effectiveness among elderly nursing home residents: a cohort study
    A S Monto
    Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA
    Am J Epidemiol 154:155-60. 2001
    ..Given the number of eligible homes and the cohort methodology used, the results support continuation of current policy, encouraging use of vaccine in all nursing home residents...
  19. ncbi Randomized, placebo-controlled studies of inhaled zanamivir in the treatment of influenza A and B: pooled efficacy analysis
    A S Monto
    Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, USA
    J Antimicrob Chemother 44:23-9. 1999
    ..001). These results highlight the groups likely to show greatest benefit from zanamivir treatment, and confirm the clinical relevance of the treatment benefit...
  20. ncbi Acute respiratory infections (ARI) in children: prospects for prevention
    A S Monto
    Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor 48109, USA
    Vaccine 16:1582-8. 1998
    ..The introduction and use of new vaccines in those regions will require demonstration of cost effectiveness and acceptance by policy makers...
  21. ncbi Effect of zanamivir on duration and resolution of influenza symptoms
    A S Monto
    Department of Epidemiology, University of Michigan School of Public Health, Ann Arhor, USA
    Clin Ther 22:1294-305. 2000
    ..Administration by inhalation results in direct delivery to the respiratory tract, the principal site of viral replication...
  22. ncbi Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections
    A S Monto
    Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA
    J Infect Dis 180:254-61. 1999
    ..It was well tolerated. These results suggest that zanamivir can significantly reduce the duration and overall symptomatic effect of influenza...
  23. ncbi Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial
    A S Monto
    School of Public Health, University of Michigan, Ann Arbor 48109 2029, USA
    JAMA 282:31-5. 1999
    ..It has also been shown to prevent influenza infection and disease in an experimental model...
  24. ncbi Individual and community impact of influenza
    A S Monto
    School of Public Health, University of Michigan, Ann Arbor, USA
    Pharmacoeconomics 16:1-6. 1999
    ..The actual impact of influenza is likely to be within this range of estimates, but recent vaccination studies suggest the possibility of much higher rates of morbidity than previously estimated...
  25. ncbi Interrupting the transmission of respiratory tract infections: theory and practice
    A S Monto
    Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor 48109, USA
    Clin Infect Dis 28:200-4. 1999
    ..Results of these experiences can in turn strengthen the development of transmission theory...
  26. ncbi Development of a predictive index for picornavirus infections
    Arnold S Monto
    Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI 48109, USA
    Clin Infect Dis 36:253-8. 2003
    ..The model was simplified for clinical use by creating a whole-number index: the lowest possible score (-3) indicates a 15% chance of picornavirus infection and the highest (7) indicates a 69% chance of picornavirus infection...
  27. ncbi Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households
    Arnold S Monto
    School of Public Health, Department of Epidemiology, University of Michigan, Ann Arbor 48109, USA
    J Infect Dis 186:1582-8. 2002
    ..Zanamivir was well tolerated and was effective in preventing influenza types A and B within households where the index patient was not treated...
  28. ncbi Person-to-person transmission of hepatitis A virus in an urban area of intermediate endemicity: implications for vaccination strategies
    J C Victor
    Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA
    Am J Epidemiol 163:204-10. 2006
    ..If vaccine is determined to be highly effective postexposure and if it is feasible, vaccinating household contacts could be a useful additional control strategy...
  29. ncbi Clinical signs and symptoms predicting influenza infection
    A S Monto
    University of Michigan, 3080 SPH 1, 109 Observatory St, Ann Arbor, MI 48109 2029, USA
    Arch Intern Med 160:3243-7. 2000
    ..In clinical practice, antiviral use has rarely been guided by antecedent laboratory diagnosis. Defined clinical predictors of an influenza infection can help guide timely therapy and avoid unnecessary antibiotic use...
  30. ncbi Ferrets as a transmission model for influenza: sequence changes in HA1 of type A (H3N2) virus
    M L Herlocher
    Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan 48109, USA
    J Infect Dis 184:542-6. 2001
    ..The results show the value of the ferret model. A/LA resembled the transmission of influenza in humans when under antibody pressure...
  31. ncbi Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets
    M Louise Herlocher
    Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan 48109, USA
    J Infect Dis 190:1627-30. 2004
    ..Both the mutant and the wild-type viruses retained their genotypic characteristics...
  32. ncbi Occurrence of respiratory virus: time, place and person
    Arnold S Monto
    Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, USA
    Pediatr Infect Dis J 23:S58-64. 2004
    ..Although vaccination and antiviral drugs are virus-specific, factors that promote transmission and thus strategies for limiting outbreaks are similar for various respiratory viruses...
  33. ncbi The threat of an avian influenza pandemic
    Arnold S Monto
    University of Michigan School of Public Health, Ann Arbor, USA
    N Engl J Med 352:323-5. 2005
  34. ncbi Reduced reaction frequencies with repeated inactivated or live-attenuated influenza vaccination
    Suzanne E Ohmit
    University of Michigan School of Public Health, Ann Arbor, MI 48109, USA
    Vaccine 27:1050-4. 2009
    ..Reaction reporting peaked on post-vaccination days 0 and 1 following receipt of the inactivated vaccine, and on day 2 following receipt of the live-attenuated vaccine...
  35. ncbi Symptomatic predictors of influenza virus positivity in children during the influenza season
    Suzanne E Ohmit
    University of Michigan School of Public Health, Ann Arbor, Michigan 48109-2029, USA
    Clin Infect Dis 43:564-8. 2006
    ....
  36. ncbi Nonpharmaceutical influenza mitigation strategies, US communities, 1918-1920 pandemic
    Howard Markel
    The University of Michigan Medical School, Ann Arbor, Michigan 48109, USA
    Emerg Infect Dis 12:1961-4. 2006
    ..We conclude that several small communities implemented potentially successful attempts at preventing the introduction of influenza...
  37. ncbi Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines
    Suzanne E Ohmit
    Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor 48109, USA
    N Engl J Med 355:2513-22. 2006
    ..The efficacy of influenza vaccines may decline during years when the circulating viruses have antigenically drifted from those included in the vaccine...
  38. ncbi Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines
    Suzanne E Ohmit
    University of Michigan School of Public Health, Department of Epidemiology, Ann Arbor, Michigan 48109, USA
    J Infect Dis 198:312-7. 2008
    ....
  39. ncbi Assessment of development of resistance to antivirals in the ferret model of influenza virus infection
    M Louise Herlocher
    Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan 48109, USA
    J Infect Dis 188:1355-61. 2003
    ..Similar to the situation in humans, amantadine use in ferrets rapidly produces antiviral resistance, but zanamivir use does not, although nucleotide changes were observed...
  40. ncbi The economic burden of non-influenza-related viral respiratory tract infection in the United States
    A Mark Fendrick
    Division of General Internal Medicine, Department of Internal Medicine, School of Medicine, University of Michigan, 300 N Ingalls Bldg, Room 7E06, Ann Arbor, MI 48109 0376, USA
    Arch Intern Med 163:487-94. 2003
    ..Our objectives were to obtain an updated incidence of non-influenza-related VRTI in the United States and to quantify the health care resource use (direct costs) and productivity losses (indirect costs) associated with these infections...
  41. ncbi Preparing for pandemic influenza: should hospitals stockpile oseltamivir?
    Sandro Cinti
    Division of Infectious Diseases, University of Michigan Health System, Ann Arbor, Michigan, USA
    Infect Control Hosp Epidemiol 26:852-4. 2005
    ..We think that hospitals should consider stockpiling oseltamivir, and we provide a strategy for doing so at a reasonable cost...
  42. ncbi Research findings from nonpharmaceutical intervention studies for pandemic influenza and current gaps in the research
    Allison E Aiello
    Center for Social Epidemiology and Population Health, Department of Epidemiology, School of Public Health, University of Michigan, 1415 Washington Heights, Ann Arbor, MI 48109, USA
    Am J Infect Control 38:251-8. 2010
    ..The current novel influenza A (H1N1) pandemic underscores the importance of influenza research...
  43. ncbi Mask use, hand hygiene, and seasonal influenza-like illness among young adults: a randomized intervention trial
    Allison E Aiello
    Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA
    J Infect Dis 201:491-8. 2010
    ..Our study examined whether use of face masks and hand hygiene reduced the incidence of influenza-like illness (ILI)...
  44. ncbi Respiratory illness caused by picornavirus infection: a review of clinical outcomes
    A S Monto
    Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, USA
    Clin Ther 23:1615-27. 2001
    ..New treatments should be assessed not only in terms of their ability to produce the desired clinical outcome, but also in terms of their ability to reduce the burden of disease, decrease health care costs, and improve productivity...
  45. ncbi Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets
    M L Herlocher
    Epidemiology, School of Public Health, University of Michigan, 109 Observatory, Ann Arbor, MI 48109, USA
    Antiviral Res 54:99-111. 2002
    ....
  46. ncbi Diagnostic testing or empirical neuraminidase inhibitor therapy for patients with influenza-like illness: what a difference a day makes
    Susan G Blitz
    Department of Internal Medicine, University of Michigan School of Medicine, Ann Arbor, USA
    Am J Manag Care 8:221-7. 2002
    ..Clinicians must consider these factors when determining cost-effective use of NIs...
  47. ncbi Epidemiology of viral respiratory infections
    Arnold S Monto
    Department of Epidemiology, School of Public Health, University of Michigan at Ann Arbor, Ann Arbor, Michigan, USA
    Am J Med 112:4S-12S. 2002
    ....
  48. ncbi Demographic and socioeconomic determinants of influenza vaccination disparities among university students
    M Uddin
    Center for Social Epidemiology and Population Health, 1415 Washington Heights, Ann Arbor, MI 48109 2029, USA
    J Epidemiol Community Health 64:808-13. 2010
    ..We therefore sought to examine the influence of demographic, social and health behaviours on influenza vaccination coverage among college dormitory students...
  49. ncbi The increasing prominence of household transmission of hepatitis A in an area undergoing a shift in endemicity
    J C Victor
    Department of Epidemiology, School of Public Health, The University of Michigan, Ann Arbor, MI 48109, USA
    Epidemiol Infect 134:492-7. 2006
    ..0, 95% confidence interval 1.3-3.2). Almaty is experiencing an epidemiological shift in hepatitis A incidence. Feasible and effective prevention strategies using hepatitis A vaccine should be explored...
  50. ncbi Hepatitis A vaccine versus immune globulin for postexposure prophylaxis
    John C Victor
    University of Michigan, Ann Arbor, USA
    N Engl J Med 357:1685-94. 2007
    ....
  51. ncbi Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents
    Richard J Whitley
    University of Alabama at Birmingham, Birmingham, AL, 35233 1711, USA
    J Infect Dis 194:S133-8. 2006
    ..The development of additional antiviral drugs is an important recommendation for the future, so that antiviral resistance can be circumvented. Similarly, availability of drugs for children <1 year of age is mandatory...
  52. ncbi A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children
    Janet A Englund
    Division of Pediatric Infectious Diseases, Allergy, and Rheumatology, University of Washington and Children s Hospital and Regional Medical Center, Seattle, Washington 98105, USA
    Pediatrics 115:1039-47. 2005
    ..Trivalent inactivated influenza vaccine (TIV) is recommended for all children ages 6 to 23 months. Delivering 2 doses of TIV at least 4 weeks apart to young children receiving this vaccine for the first time is challenging...
  53. ncbi Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice
    Hui-Ling Yen
    Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee 38105-2794, USA
    J Infect Dis 192:665-72. 2005
    ..CONCLUSIONS. Oseltamivir prophylaxis is efficacious against lethal challenge with VN1203/04 virus in mice. Viral virulence may affect the antiviral treatment schedule...
  54. ncbi Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility
    Hui-Ling Yen
    Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105-2794, USA
    Antimicrob Agents Chemother 49:4075-84. 2005
    ..Our results suggest that NAI-resistant influenza virus variants may differ substantially in fitness and transmissibility, depending on different levels of NA functional loss...
  55. ncbi Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses
    Hui-Ling Yen
    Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN 38105-2794, USA
    J Virol 80:8787-95. 2006
    ..The results of our study may help to optimize the design of NAIs...
  56. ncbi Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Emmanuel B Walter
    Duke Clinical Research Institute, Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA
    Pediatrics 118:e570-8. 2006
    ....
  57. ncbi Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers
    Janet A Englund
    Pediatric ID, Children s Hospital and Regional Medical Center, 4800 Sand Point Way, NE W8851, Seattle, Washington 98105, USA
    Pediatrics 118:e579-85. 2006
    ....
  58. ncbi Seasonal and pandemic influenza: recommendations for preparedness in the United States
    Richard J Whitley
    Department of Pediatric, University of Alabama at Birmingham, Birmingham, AL, 35233 1711, USA
    J Infect Dis 194:S155-61. 2006
    ....
  59. ncbi Seasonal and pandemic influenza preparedness: a global threat
    Richard J Whitley
    Departments of Pediatrics, Microbiology, Medicine, and Neurosurgery and Center for Biodefense and Emerging Infections, University of Alabama at Birmingham, Birmingham, AL, 35233 1711, USA
    J Infect Dis 194:S65-9. 2006
    ....
  60. ncbi Editorial commentary: viral susceptibility and the choice of influenza antivirals
    Arnold S Monto
    Clin Infect Dis 47:346-8. 2008
  61. ncbi Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans
    Lance C Jennings
    Microbiology Department, Canterbury Health Laboratories, University of Otago, Christchurch, New Zealand
    Lancet Infect Dis 8:650-8. 2008
    ..WHO and governments should give urgent consideration to the use of these vaccines for the priming of individuals or communities who would be at greatest risk of infection if an H5N1 influenza pandemic were to emerge...
  62. ncbi Antiviral effects on influenza viral transmission and pathogenicity: observations from household-based trials
    M Elizabeth Halloran
    Program in Biostatistics and Biomathematics, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Am J Epidemiol 165:212-21. 2007
    ..Studies of influenza antivirals in transmission units would be improved if randomization schemes were used that allow estimation of the antiviral effect on infectiousness from individual studies...
  63. ncbi Antivirals for influenza in healthy adults
    Arnold S Monto
    Lancet 367:1571-2; author reply 1573. 2006
  64. ncbi Echinacea purpurea for prevention of experimental rhinovirus colds
    Steven J Sperber
    Department of Internal Medicine, Hackensack University Medical Center, Hackensack, NJ 07601, USA
    Clin Infect Dis 38:1367-71. 2004
    ....
  65. ncbi A study of influenza and influenza-related complications among children in a large US health insurance plan database
    Jeanne Loughlin
    Ingenix Epidemiology Division, Newton, Massachusetts 02466, USA. .com
    Pharmacoeconomics 21:273-83. 2003
    ....

Research Grants2

  1. Comparative Study of Influenza Vaccines in Adults
    ARNOLD MONTO; Fiscal Year: 2006
    ..Results will help to determine how the vaccine may be used as part of the strategy to combat influenza in varying situations. ..